Danish biotech Zealand Pharma is targeting the “next generation” of weight loss drugs as competitors pile into a market dominated by heavyweights Novo Nordisk and Eli Lilly.
Related Posts
Traders bet on more Bank of England rate cuts in 2025 after data shocks
The disappointing retail data adds to the dim economic picture in the U.K. and to the challenges facing Finance Minister…
Meet PII Masker: An Open-Source Tool for Protecting Sensitive Data by Automatically Detecting and Masking PII Using Advanced AI Powered by DeBERTa-v3
In a data-driven world, privacy and security have become pressing concerns for individuals and organizations alike. With data breaches and…
Meet Ivy-VL: A Lightweight Multimodal Model with Only 3 Billion Parameters for Edge Devices
The ongoing advancement in artificial intelligence highlights a persistent challenge: balancing model size, efficiency, and performance. Larger models often deliver…